Page 7 - Practice Research News Today

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell LymphomaMinjuvi

BOSTON, MA / ACCESSWIRE / March 15, 2022 / MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE:MOR)(NASDAQ:MOR), announced today that the National Comprehensive Cancer Network(R) (NCCN)

DGAP-News: MorphoSys AG / Key word(s): Miscellaneous15.03.2022 / 21:01 The issuer is solely responsible for the content of this announcement.Media ReleaseNational Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in its Clinical Practice Guidelines in Oncology...

National Comprehensive Cancer Network® Updates Designation of Monjuvi® to Preferred Regimen in its Clinical Practice Guidelines in Oncology for B-cell Lymphomas BOSTON,... | March 15, 2022

Through research in regenerative medicine, advancement has been shown to improve and treat diseases ..

DGAP-News: MorphoSys AG / Key word(s): Miscellaneous/Conference11.12.2021 / 18:00 The issuer is solely responsible for the content of this announcement.MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatme...

- RE-MIND2 compared patient outcomes from pivotal L-MIND study with matched patient populations treated with NCCN/ESMO recommended therapies- Results from the retrospective cohort analysis indicate significant

- Entscheidung der Kommission basiert auf Daten aus der Studie L-MIND zur Prüfung von Minjuvi in Kombination mit Lenalidomid als Behandlung von Patienten mit rezidiviertem oder refraktärem DLBCL -

Date Time Role for GPs in heart-risk hunt GP clinics could be enlisted to help identify patients unknowingly at risk of a premature heart attack and early death due to an inherited condition, a Department of Health-funded study has found. The newly published research found that GP clinics could not only play a pivotal role in identifying patients with the condition familial hypercholesterolaemia (FH), but also in managing their ongoing treatment. Lead researcher and Notre Dame Professor of Gene...

Sağlıklı Kilo Vermenin 10 Yolu! Eklenme Tarihi: 12.07.2021 01:39 Güncellenme: 12.07.2021 01:41 Sağlıklı Kilo Vermenin 10 Yolu! Özellikle teknoloji söz konusu olduğunda, birçok kaynağın mevcut olduğu bir dünyada yaşıyoruz. Ne yazık ki, tüm bu gelişmeler hareket ihtiyacını azaltarak hareketsiz kalmamıza neden oldu.   1. Düşük Karbonhidrat Alımı En iyi diyet planını belirlerken proteinler, karbonhi...